Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey

Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey

Abstract Background Gestational diabetes (GDM) is associated with an increased lifetime risk for the development of glucose abnormalities, metabolic syndrome, cardiovascular disease, depression and tumours. Despite this high risk of additional comorbidities, there is no standardised approach to the...

Full description

Bibliographic Details
Main Authors: Delia Bogdanet, Aoife Egan, Narjes Fhelelboom, Linda Biesty, Shakila Thangaratinam, Eugene Dempsey, Caroline Crowther, Declan Devane, Fidelma Dunne
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Trials
Subjects:
Core outcome set
Gestational diabetes
Insulin
Oral hypoglycaemic agents
Online Access:http://link.springer.com/article/10.1186/s13063-018-3059-8

Internet

http://link.springer.com/article/10.1186/s13063-018-3059-8

Similar Items